Eupraxia Pharmaceuticals (EPRXF, $4.35) was one of top quarterly gainers, jumping +4 to $4.35 per share. A.I.dvisor analyzed 960 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on August 12, 2025. You can read more about the earnings report here.